Key result
Circadian-synchronized delivery of cardiovascular medications is proposed to address the uneven 24-hour distribution of acute cardiovascular events and peak morning susceptibility.
Answers are grounded in this paper and cite their sources.
The delivery of cardiovascular medications should be synchronized with circadian rhythms to match the temporal patterns of cardiovascular risk and optimize therapeutic efficacy.
The scientific literature clearly establishes the occurrence of cardiovascular (CV) accidents and myocardial ischemic episodes is unevenly distributed during the 24 h. Such temporal patterns result from corresponding temporal variation in pathophysiologic mechanisms and cyclic environmental triggers that elicit the onset of clinical events. Moreover, both the pharmacokinetics and pharmacodynamics of many, though not all, CV medications have been shown to be influenced by the circadian time of their administration, even though further studies are necessary to better clarify the mechanisms of such influence on different drug classes, drug molecules, and pharmaceutical preparations. Twenty-four-hour rhythmic organization of CV functions is such that defense mechanisms against acute events are incapable of providing the same degree of protection during the day and night. Instead, temporal gates of excessive susceptibility exist, particularly in the morning and to a lesser extent evening (in diurnally active persons), to aggressive mechanisms through which overt clinical manifestations may be triggered. When peak levels of critical physiologic variables, such as blood pressure (BP), heart rate (HR), rate pressure product (systolic BP × HR, surrogate measure of myocardial oxygen demand), sympathetic activation, and plasma levels of endogenous vasoconstricting substances, are aligned together at the same circadian time, the risk of acute events becomes significantly elevated such that even relatively minor and usually harmless physical and mental stress and environmental phenomena can precipitate dramatic life-threatening clinical manifestations. Hence, the delivery of CV medications needs to be synchronized in time, i.e., circadian time, in proportion to need as determined by established temporal patterns in risk of CV events, and in a manner that averts or minimizes undesired side effects.
No takes yet. Share an insight, caveat, or question.
Manfredini et al. (2012) conducted a review in Acute cardiovascular events and ischemic heart disease. Circadian-synchronized cardiovascular medications was evaluated. Circadian-synchronized delivery of cardiovascular medications is proposed to address the uneven 24-hour distribution of acute cardiovascular events and peak morning susceptibility.
Synapse has enriched 10 related papers. Consider them for comparative context: